Literature DB >> 33518400

p53 and Tumor Suppression: It Takes a Network.

Anthony M Boutelle1, Laura D Attardi2.   

Abstract

The TP53 tumor suppressor is the most frequently mutated gene in human cancer. p53 suppresses tumorigenesis by transcriptionally regulating a network of target genes that play roles in various cellular processes. Though originally characterized as a critical regulator for responses to acute DNA damage (activation of apoptosis and cell cycle arrest), recent studies have highlighted new pathways and transcriptional targets downstream of p53 regulating genomic integrity, metabolism, redox biology, stemness, and non-cell autonomous signaling in tumor suppression. Here, we summarize our current understanding of p53-mediated tumor suppression, situating recent findings from mouse models and unbiased screens in the context of previous studies and arguing for the importance of the pleiotropic effects of the p53 transcriptional network in inhibiting cancer.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; mouse models; network; p53; transcription factor; tumor suppression

Mesh:

Substances:

Year:  2021        PMID: 33518400      PMCID: PMC7954925          DOI: 10.1016/j.tcb.2020.12.011

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  84 in total

1.  Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms.

Authors:  Marco Bezzi; Nina Seitzer; Tomoki Ishikawa; Markus Reschke; Ming Chen; Guocan Wang; Caitlin Mitchell; Christopher Ng; Jesse Katon; Andrea Lunardi; Sabina Signoretti; John G Clohessy; Jiangwen Zhang; Pier Paolo Pandolfi
Journal:  Nat Med       Date:  2018-01-08       Impact factor: 53.440

2.  p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.

Authors:  Liz J Valente; Daniel H D Gray; Ewa M Michalak; Josefina Pinon-Hofbauer; Alex Egle; Clare L Scott; Ana Janic; Andreas Strasser
Journal:  Cell Rep       Date:  2013-05-09       Impact factor: 9.423

Review 3.  Deconstructing networks of p53-mediated tumor suppression in vivo.

Authors:  Alyssa M Kaiser; Laura D Attardi
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

4.  Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression.

Authors:  Shang-Jui Wang; Dawei Li; Yang Ou; Le Jiang; Yue Chen; Yingming Zhao; Wei Gu
Journal:  Cell Rep       Date:  2016-10-04       Impact factor: 9.423

Review 5.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Authors:  Flore Kruiswijk; Christiaan F Labuschagne; Karen H Vousden
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07       Impact factor: 94.444

6.  p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase.

Authors:  Peng Jiang; Wenjing Du; Xingwu Wang; Anthony Mancuso; Xiang Gao; Mian Wu; Xiaolu Yang
Journal:  Nat Cell Biol       Date:  2011-02-20       Impact factor: 28.824

7.  Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses.

Authors:  Le Jiang; Justin H Hickman; Shang-Jui Wang; Wei Gu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression.

Authors:  George Hinkal; Neha Parikh; Lawrence A Donehower
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

9.  p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells.

Authors:  Alexandre Iannello; Thornton W Thompson; Michele Ardolino; Scott W Lowe; David H Raulet
Journal:  J Exp Med       Date:  2013-09-16       Impact factor: 14.307

10.  Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53.

Authors:  Angustias Page; Manuel Navarro; Cristian Suarez-Cabrera; Josefa P Alameda; M Llanos Casanova; Jesús M Paramio; Ana Bravo; Angel Ramirez
Journal:  Oncotarget       Date:  2016-04-12
View more
  41 in total

1.  FOXO4 interacts with p53 TAD and CRD and inhibits its binding to DNA.

Authors:  Raju Mandal; Klara Kohoutova; Olivia Petrvalska; Matej Horvath; Pavel Srb; Vaclav Veverka; Veronika Obsilova; Tomas Obsil
Journal:  Protein Sci       Date:  2022-05       Impact factor: 6.725

2.  Decreased DNA Damage and Improved p53 Specificity of RITA Analogs.

Authors:  Yue Zhan; Xiaolei Zhou; Sylvain Peuget; Madhurendra Singh; Brian D Peyser; Zhimin Fan; Galina Selivanova
Journal:  Mol Cancer Ther       Date:  2022-10-07       Impact factor: 6.009

Review 3.  Regulated cell death (RCD) in cancer: key pathways and targeted therapies.

Authors:  Fu Peng; Minru Liao; Rui Qin; Shiou Zhu; Cheng Peng; Leilei Fu; Yi Chen; Bo Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

4.  Distinct p53 isoforms code for opposing transcriptional outcomes.

Authors:  Annika Wylie; Amanda E Jones; Simanti Das; Wan-Jin Lu; John M Abrams
Journal:  Dev Cell       Date:  2022-07-11       Impact factor: 13.417

5.  Empirical single-cell tracking and cell-fate simulation reveal dual roles of p53 in tumor suppression.

Authors:  Ann Rancourt; Sachiko Sato; Masahiko S Satoh
Journal:  Elife       Date:  2022-09-20       Impact factor: 8.713

6.  Zmat3 splices together p53-dependent tumor suppression.

Authors:  Kathryn T Bieging-Rolett; Laura D Attardi
Journal:  Mol Cell Oncol       Date:  2021-04-29

7.  Loss of Ribosomal Protein Paralog Rpl22-like1 Blocks Lymphoid Development without Affecting Protein Synthesis.

Authors:  Shawn P Fahl; Robert Sertori; Yong Zhang; Alejandra V Contreras; Bryan Harris; Minshi Wang; Jacqueline Perrigoue; Siddharth Balachandran; Brian K Kennedy; David L Wiest
Journal:  J Immunol       Date:  2022-01-19       Impact factor: 5.422

8.  p53-mediated G1 arrest requires the induction of both p21 and Killin in human colon cancer cells.

Authors:  Dan Luo; Chune Yu; Jing Yu; Chao Su; Shun Li; Peng Liang
Journal:  Cell Cycle       Date:  2021-12-08       Impact factor: 4.534

Review 9.  Obscurin: A multitasking giant in the fight against cancer.

Authors:  Talia Guardia; Matthew Eason; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-05-18       Impact factor: 11.414

10.  iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4.

Authors:  Delin Chen; Bo Chu; Xin Yang; Zhaoqi Liu; Ying Jin; Ning Kon; Raul Rabadan; Xuejun Jiang; Brent R Stockwell; Wei Gu
Journal:  Nat Commun       Date:  2021-06-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.